Literature DB >> 29191123

Patient Perceptions of Barriers to Self-Management of Breast Cancer-Related Lymphedema.

Pamela L Ostby1, Jane M Armer1, Kandis Smith1, Bob R Stewart1.   

Abstract

Breast cancer survivors are at lifetime risk for the development of breast cancer-related lymphedema, a chronic, potentially debilitating condition that requires life-long symptom management. Suboptimal self-management rates suggest that health care providers may not be offering educative-support options that are customized to patient-perceived needs. An Institutional Review Board-approved focus group ( N = 9) and mailed surveys ( N = 15) were used to identify (a) barriers to lymphedema self-management, (b) how breast cancer survivors with lymphedema defined education and support, (c) what type of education and support they had received, and (d) what kind of education and support they wanted. Physiological, psychological, and psychosocial factors were identified as barriers to successful lymphedema self-management. One of the main barriers identified was lack of education about lymphedema treatment and risk reduction. In addition, more than half defined support as "prescriptions" and "referrals"; therefore, it is unclear whether patients were exposed to support other than medical treatment.

Entities:  

Keywords:  lymphedema; patient compliance; patient education; self-care; social support

Mesh:

Year:  2017        PMID: 29191123      PMCID: PMC6057842          DOI: 10.1177/0193945917744351

Source DB:  PubMed          Journal:  West J Nurs Res        ISSN: 0193-9459            Impact factor:   1.967


  37 in total

1.  Cognitive science speaks to the "common-sense" of chronic illness management.

Authors:  Howard Leventhal; Elaine A Leventhal; Jessica Y Breland
Journal:  Ann Behav Med       Date:  2011-04

2.  The Common-Sense Model of Self-Regulation (CSM): a dynamic framework for understanding illness self-management.

Authors:  Howard Leventhal; L Alison Phillips; Edith Burns
Journal:  J Behav Med       Date:  2016-08-11

3.  Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions.

Authors:  Sarah A McLaughlin; Alicia C Staley; Frank Vicini; Paul Thiruchelvam; Nancy A Hutchison; Jane Mendez; Fiona MacNeill; Stanley G Rockson; Sarah M DeSnyder; Suzanne Klimberg; Michael Alatriste; Francesco Boccardo; Mark L Smith; Sheldon M Feldman
Journal:  Ann Surg Oncol       Date:  2017-08-01       Impact factor: 5.344

4.  The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors.

Authors:  Mei R Fu; Constance M Chen; Judith Haber; Amber A Guth; Deborah Axelrod
Journal:  Ann Surg Oncol       Date:  2010-02-06       Impact factor: 5.344

5.  Limitations of self-care in reducing the risk of lymphedema: supportive-educative systems.

Authors:  Jane M Armer; Constance W Brooks; Bob R Stewart
Journal:  Nurs Sci Q       Date:  2011-01       Impact factor: 0.883

6.  Psychosocial factors associated with adherence for self-management behaviors in women with breast cancer-related lymphedema.

Authors:  Jessica Alcorso; Kerry A Sherman; Louise Koelmeyer; Helen Mackie; John Boyages
Journal:  Support Care Cancer       Date:  2015-05-10       Impact factor: 3.603

7.  The Diagnosis and Treatment of Peripheral Lymphedema: 2016 Consensus Document of the International Society of Lymphology.

Authors: 
Journal:  Lymphology       Date:  2016-12       Impact factor: 1.286

8.  Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system.

Authors:  Marilyn L Kwan; Ling Shen; Julie R Munneke; Emily K Tam; Paula N Partee; Mary André; Susan E Kutner; Carol P Somkin; Lynn M Ackerson; Saskia R J Thiadens
Journal:  Breast Cancer Res Treat       Date:  2012-08-19       Impact factor: 4.872

Review 9.  Psychosocial impact of living with cancer-related lymphedema.

Authors:  Mei R Fu; Yang Kang
Journal:  Semin Oncol Nurs       Date:  2013-02       Impact factor: 2.315

10.  Breast cancer survivors' perspectives of critical lymphedema self-care support needs.

Authors:  Sheila H Ridner; Bethany A Rhoten; M Elise Radina; Melissa Adair; Sydney Bush-Foster; Vaughn Sinclair
Journal:  Support Care Cancer       Date:  2016-01-26       Impact factor: 3.603

View more
  8 in total

Review 1.  Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review.

Authors:  L H Eaton; N Narkthong; J M Hulett
Journal:  Curr Breast Cancer Rep       Date:  2020-08-25

2.  Breast cancer-related lymphedema patient and healthcare professional experiences in lymphedema self-management: a qualitative study.

Authors:  Huihui Zhao; Yanni Wu; Chunlan Zhou; Wenji Li; Xiaojin Li; Liling Chen
Journal:  Support Care Cancer       Date:  2021-07-05       Impact factor: 3.603

3.  Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1.

Authors:  Ruoming Wang; Tengteng Zhang; Zhen Yang; Chunxia Jiang; Jingjing Seng
Journal:  J Cell Mol Med       Date:  2018-07-03       Impact factor: 5.310

Review 4.  Healthcare Practitioners' Knowledge of Lymphedema.

Authors:  Hossein Yarmohammadi; Amirhossein Rooddehghan; Masood Soltanipur; Amirabbas Sarafraz; Seyed Fatah Mahdavi Anari
Journal:  Int J Vasc Med       Date:  2021-12-31

5.  Effectiveness of virtual reality-based interventions in rehabilitation management of breast cancer survivors: protocol of a systematic review and meta-analysis.

Authors:  Xiaofan Bu; Peter H F Ng; Qi Chen; Andy S K Cheng; Wenjing Xu; Ying Tong; Qingping Tang; Xiangyu Liu
Journal:  BMJ Open       Date:  2022-02-16       Impact factor: 2.692

Review 6.  The Effectiveness of Virtual Reality-Based Interventions in Rehabilitation Management of Breast Cancer Survivors: Systematic Review and Meta-analysis.

Authors:  Xiaofan Bu; Peter Hf Ng; Wenjing Xu; Qinqin Cheng; Peter Q Chen; Andy Sk Cheng; Xiangyu Liu
Journal:  JMIR Serious Games       Date:  2022-02-28       Impact factor: 3.364

7.  Update to the Canadian clinical practice guideline for best-practice management of breast cancer-related lymphedema: study protocol.

Authors:  Margaret Lynn McNeely; Susan R Harris; Naomi D Dolgoy; Mona M Al Onazi; Joanna F Parkinson; Lori Radke; Xanthoula Kostaras; Liz Dennett; Jean Ann Ryan; Mary-Ann Dalzell; Anna Kennedy; Lauren Capozzi; Anna Towers; Kristin L Campbell; Jill Binkley; Karen King; David Keast
Journal:  CMAJ Open       Date:  2022-04-12

8.  Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, an Open-Label Controlled Study.

Authors:  Stanley G Rockson; Pinar Karaca-Mandic; Roman Skoracki; Karen Hock; Michelle Nguyen; Kristin Shadduck; Phyllis Gingerich; Elizabeth Campione; Andrea Leifer; Jane Armer
Journal:  Lymphat Res Biol       Date:  2021-07-02       Impact factor: 2.349

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.